Chloe Thio
Chloe Thio
Verified email at
Cited by
Cited by
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
DL Thomas, CL Thio, MP Martin, Y Qi, D Ge, C O’hUigin, J Kidd, K Kidd, ...
Nature 461 (7265), 798-801, 2009
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection
SI Khakoo, CL Thio, MP Martin, CR Brooks, X Gao, J Astemborski, ...
Science 305 (5685), 872-874, 2004
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
CL Thio, EC Seaberg, R Skolasky Jr, J Phair, B Visscher, A Muņoz, ...
The Lancet 360 (9349), 1921-1926, 2002
Clinical implications of HIV and hepatitis B co-infection in Asia and Africa
CJ Hoffmann, CL Thio
The Lancet infectious diseases 7 (6), 402-409, 2007
Hepatitis B and human immunodeficiency virus coinfection
CL Thio
Hepatology 49 (S5), S138-S145, 2009
The HBV drug entecavir—effects on HIV-1 replication and resistance
MA McMahon, BL Jilek, TP Brennan, L Shen, Y Zhou, M Wind-Rotolo, ...
New England Journal of Medicine 356 (25), 2614-2621, 2007
Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV–HBV International Panel
V Soriano, M Puoti, M Bonacini, G Brook, A Cargnel, J Rockstroh, C Thio, ...
Aids 19 (3), 221-240, 2005
IL28B and the control of hepatitis C virus infection
A Balagopal, DL Thomas, CL Thio
Gastroenterology 139 (6), 1865-1876, 2010
Racial differences in HLA class II associations with hepatitis C virus outcomes
CL Thio, DL Thomas, JJ Goedert, D Vlahov, KE Nelson, MW Hilgartner, ...
The Journal of infectious diseases 184 (1), 16-21, 2001
HLA-Cw* 04 and hepatitis C virus persistence
CL Thio, X Gao, JJ Goedert, D Vlahov, KE Nelson, MW Hilgartner, ...
Journal of virology 76 (10), 4792-4797, 2002
Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy
GV Matthews, A Bartholomeusz, S Locarnini, A Ayres, J Sasaduesz, ...
Aids 20 (6), 863-870, 2006
Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection
CL Thio, DL Thomas, P Karacki, X Gao, D Marti, RA Kaslow, JJ Goedert, ...
Journal of Virology 77 (22), 12083-12087, 2003
Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts
P Duggal, CL Thio, GL Wojcik, JJ Goedert, A Mangia, R Latanich, AY Kim, ...
Annals of internal medicine 158 (4), 235-245, 2013
Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B
CJ Hoffmann, S Charalambous, CL Thio, DJ Martin, L Pemba, KL Fielding, ...
Aids 21 (10), 1301-1308, 2007
Liver disease in the HIV–infected individual
JC Price, CL Thio
Clinical Gastroenterology and Hepatology 8 (12), 1002-1012, 2010
Screening for hepatitis C virus in human immunodeficiency virus-infected individuals
CL Thio, KR Nolt, J Astemborski, D Vlahov, KE Nelson, DL Thomas
Journal of clinical microbiology 38 (2), 575-577, 2000
Hepatitis B in the human immunodeficiency virus-infected patient: epidemiology, natural history, and treatment
CL Thio
Seminars in liver disease 23 (2), 125-136, 2003
Class II HLA alleles and hepatitis B virus persistence in African Americans
CL Thio, M Carrington, D Marti, SJ O'Brien, D Vlahov, KE Nelson, ...
The Journal of infectious diseases 179 (4), 1004-1006, 1999
Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program
CJ Hoffmann, S Charalambous, DJ Martin, C Innes, GJ Churchyard, ...
Clinical Infectious Diseases 47 (11), 1479-1485, 2008
Incident hepatitis C virus infection in men who have sex with men: a prospective cohort analysis, 1984–2011
MD Witt, EC Seaberg, A Darilay, S Young, S Badri, CR Rinaldo, ...
Clinical infectious diseases 57 (1), 77-84, 2013
The system can't perform the operation now. Try again later.
Articles 1–20